Multiparticulate Technologies for Pediatric Products and Formulation Considerations and Strategies for Pediatrics

This presentation examines the advantages of using multiparticulates as a pediatric dosage form, particularly early in the drug-development process. Often development of age-appropriate dosage forms does not begin until after proof of concept, but a case study is presented showing how lipid multiparticulates can be used in early-stage development, speeding time to clinic and minimizing the use of valuable active ingredient. To learn more, please see our presentation.